ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Tra

ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript February 28, 2024 ImmuCell Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to the ImmuCell Corporation reports Fourth Quarter and Year Ended December 31, 2023 Unaudited Financial […]

Related Keywords

, Corporate Presentation , Easiest Languages , English Speakers , Joe Diaz , Michael Brigham , Financial Results , Forward Looking Statements , Contamination , Immucell , Future Events , Lytham Partners ,